Sun Pharmaceutical Industries Ltd

Healthcare

NSE: SUNPHARMABSE: 524715

₹1,780.6+₹24.4+1.39%

Mkt Cap₹4.3L Cr

P/E36.4

P/B6.4

ROE18.4%

52W High₹2,126.65

52W Low₹1,408.85

Customise metrics bar

P/B Ratio

6.4

ROE

18.4%

Dividend Yield

0.73%

Sector

Healthcare

Company Overview

Industry

Pharmaceuticals

Founded

1983

Employees

43,000

Headquarters

Mumbai, Maharashtra

Website

www.sunpharma.com

About

Sun Pharmaceutical Industries is India's largest pharmaceutical company and the fourth-largest specialty generic pharmaceutical company globally. It manufactures and markets a wide range of branded and generic formulations and APIs across more than 100 countries.

Key Management

Dilip Shanghvi

Founder & MD

C.S. Muralidharan

CFO

AI Insights· Sun Pharmaceutical Industries Ltd

Ask AI Insights

Select a prompt below to get instant market analysis.

Suggested Prompts

Recent Announcements

06 Feb 2026

Q3 FY26 Revenue ₹13,840 Cr; US specialty business contribution up 42% YoY

SUNPHARMA

₹1,780.6

+1.39%